ArticleCancer biology & medicine2025

Phase I clinical study of humanized BCMA-single-domain antibodies targeting CAR-T in patients with relapsed or refractory multiple myeloma.

Gaofeng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.